In this Voices interview, Senior Vice President of Post Acute Sales at Dragonfly Health, Kristin Nelson, sits down with Hospice News to explore how the organization is redefining continuity across care transitions. Nelson shares how Dragonfly Health’s acquisition of Enclara Pharmacia will enable more streamlined, tech-enabled workflows, reducing friction for clinicians while improving experiences for patients and families. She also highlights how predictive data, interoperability, and a combined pharmacy and DME model are helping drive scalable, sustainable hospice operations.
Hospice News: What life or career experiences have most shaped your approach to the work you’re doing today?
Kristin Nelson: My perspective is shaped by more than a decade of leading sales and strategy in the post-acute space, most recently at Dragonfly Health. Prior to that, I worked in implementation and business development at Enclara Pharmacia. Those roles taught me two things: first, that the best solutions are built at the intersection of clinical insight and operational execution; and second, that transitions of care are where everything can either come together or fall apart. I’ve seen firsthand how a poorly managed handoff can undo hard-won progress for a patient and family—and how a well-orchestrated one can enhance confidence and dignity. That’s why I’m passionate about designing systems that remove friction for clinicians and make continuity the default, not the exception.
How will Dragonfly Health’s recent acquisition of Enclara Pharmacia enhance your ability to support providers and patients during transitions of care?
Having previously acquired a smaller hospice pharmacy, we have already explored some of the myriad opportunities to elevate the nurse and patient experience while helping organizations meet their strategic goals. Enclara gives us the scale and resources we need to achieve our vision of a comprehensive, integrated DME, pharmacy, and combined solutions platform in the hospice and post-acute space. Practically, that means fewer disruptions at the bedside. Clinicians can coordinate one plan across equipment and medications, align delivery and titration with the care plan, and keep formularies and device choices consistent as patients move between settings. On the technology side, we have a strong foundation with Enclara Pharmacia’s E3 Pro™ medication management platform and Dragonfly Health’s DMETrack system. Both companies also have full-featured, innovative integrations with EMR/EHR systems large and small, so data flows with the patient record. We’re also combining decades of pharmacy and DME data to power predictive insights, helping teams anticipate needs before a transition. The end result will be fewer equipment swaps, smoother medication starts, and less administrative burden for clinicians.
